Article Details
Retrieved on: 2025-05-13 14:56:03
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Alzheimer's disease immunotherapy focused on amyloid beta, exploring active and passive antibody approaches to reduce amyloid plaques in the brain. Key studies on different antibody types and their effects, including risks like ARIA, are addressed, demonstrating the relevance of molecular neuroscience and immunotherapy in Alzheimer's research.
Article found on: molecularneurodegeneration.biomedcentral.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here